ClinicalTrials.gov
ClinicalTrials.gov Menu

The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors (IBS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03178877
Recruitment Status : Completed
First Posted : June 7, 2017
Last Update Posted : June 7, 2017
Sponsor:
Information provided by (Responsible Party):
Ari Fahrial Syam, Indonesia University

Brief Summary:
A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects.

Condition or disease Intervention/treatment
IBS - Irritable Bowel Syndrome Other: No intervention

Detailed Description:
A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects. A bivariate analysis was done to know the relationship between IBS and its related factors using chi-square, unpaired t-test, and their alternatives. Multivariate analysis was done using logistic regression test

Study Type : Observational [Patient Registry]
Actual Enrollment : 350 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 1 Day
Official Title: The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors
Actual Study Start Date : November 1, 2016
Actual Primary Completion Date : December 31, 2016
Actual Study Completion Date : December 31, 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Group/Cohort Intervention/treatment
IBS
IBS group is medical student who filled Rome IV criteria for IBS
Other: No intervention
Non IBS
Non-IBS group is non IBS medical student based on Rome IV criteria
Other: No intervention



Primary Outcome Measures :
  1. Anxiety and depression [ Time Frame: 1 month ]
    Anxiety and Depression using Hospital Anxiety Depression Scale


Secondary Outcome Measures :
  1. Sleep Quality [ Time Frame: 1 month ]
    Sleep quality using Pittsburg Sleep Quality Index

  2. Spiritual status [ Time Frame: 1 month ]
    Spiritual status using Functional Assessment of Chronic Illness Therapy-Spiritual Wellbeing

  3. Academic Stress [ Time Frame: 6 months ]
    Academic stress using Student-Life Stress Inventory



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Medical student from first grade to fifth grade
Criteria

Inclusion Criteria:

  • Age of participant >= 15 years
  • Volunteer to participate in study

Exclusion Criteria:

  • Red flag symptoms: febrile, vomiting, rectal bleeding, weight lost
  • Diagnosed as having Inflammatory bowel disease
  • Peptic ulcer drug consumption
  • History of gastrointestinal surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03178877


Locations
Indonesia
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
Sponsors and Collaborators
Indonesia University

Responsible Party: Ari Fahrial Syam, Medical Doctor, Gastroenterology Hepatology Consultant, Indonesia University
ClinicalTrials.gov Identifier: NCT03178877     History of Changes
Other Study ID Numbers: 16-11-430
First Posted: June 7, 2017    Key Record Dates
Last Update Posted: June 7, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Not available to other researcher

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Ari Fahrial Syam, Indonesia University:
IBS, Rome IV criteria, anxiety

Additional relevant MeSH terms:
Syndrome
Irritable Bowel Syndrome
Disease
Pathologic Processes
Colonic Diseases, Functional
Colonic Diseases
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases